HIV infection among homosexual/bisexual males attending genitourinary clinics in Scotland

Sexually Transmitted Infections

Volumn 74, Issue 3, 1998, Pages 185-188

  Goldberg, D ^a   Scott, G ^b   Weir, M ^c   Cameron, S ^a   Peutherer, J ^d   McMillan, A ^b   Leadbetter, G ^d   Scoular, A ^e   Codere, G ^a   Allardice, G ^a  

^a RUCHILL HOSPITAL   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d CITY HOSPITAL   (United Kingdom)

^e GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

HIV; Homosexual men; Scotland; Unlinked anonymous HIV testing

Indexed keywords

ARTICLE; BISEXUALITY; CONTROLLED STUDY; EARLY DIAGNOSIS; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; UNITED KINGDOM; VIRUS TRANSMISSION;

EID: 7344222067     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.74.3.185     Document Type: Article

References (18)

1. Robertson JR, Bucknall ABV, Welsby PD, et al. Epidemic of AIDS related virus (HTLV III/LAV) infection among intravenous drug users. BMJ 1986;292:527-29.
2. HIV Infection and AIDS. Quarterly Report to 31 December 1996. ANSWER (AIDS News Supplement to the Weekly Report) 1997:AM-31 No 13.
3. Barbara JAJ, Salker R, Challis P, et al. Gelatin particle agglutination assay for HIV antibodies: a rapid, economical modification with increased sensitivity. Med Lab Sci 1989;135-40.
4. PHLS AIDS Centre, PHLS Virus Reference Laboratory, PHLS Statistics Unit, Academic Department of Genitourinary Medicine University College and Middlesex School of Medicine, and Collaborators. Unlinked anonymous monitoring of HIV prevalence in England and Wales: 1990-92. Commun Dis Rep 1993;3:R1 11.
5. Unlinked Anonymous HIV Prevalence Monitoring Programme England and Wales. Report from the Unlinked Anonymous Surveys Steering Group. (Chairman: Dr Jeremy Metters, Dept of Health). Data to the end of 1995.
6. Goldberg DJ. New HIV infections among men who have sex with men, Scotland 1989-1994. ANSWER (AIDS News Supplement to the Weekly Report) 1995:AM-8 No 95/08.
7. Catchpole MA, Mercey DE, Nicoll A, et al. Continuing transmission of sexually transmitted diseases among patients infected with HIV-1 attending genitourinary medicine clinics in England and Wales. BMJ 1996;312: 531-42.
8. Williams DI, Stephenson JM, Hart GJ, et al. A case control study of HIV seroconversion in gay men, 1988-1993: what arc the current risk factors? Genitourin Med 1996;72:193 6.
9. AIDS (Control) Act 1995 96. Lothian Health Board.
10. AIDS (Control) Act 1995-96. Greater Glasgow Health Board.
11. Hart G, Flowers P. A survey of gay men's sexual behaviour in Glasgow. MRC Medical Sociology Unit, University of Glasgow. Report to the Greater Glasgow Health Board 1996.
12. Scoular A, Kay E, Bell J, et al. Specific health services for gay men - are they needed? Poster presentation MSSVD spring meeting, 1995.
13. AIDS and severe HIV-related disease in Scotland predictions to the end of 1999. A report by a working group convened by the Chief Medical Officer for Scotland. ANSWER (AIDS News Supplement to the Weekly Report) 1995;AM-18-WR 95/52.
14. HIV and AIDS Surveillance in Scotland. Review of the Epidemic to December 1994. ANSWER (AIDS News Supplement to the Weekly Report) December 1995: special edition.
15. Report of an Expert Group (Chairman: Professor NE Day) convened by the Director of the Public Health Laboratory Service on behalf of the Chief Medical Officers. The incidence and prevalence of AIDS and prevalence of other severe HIV disease in England and Wales for 1995 to 1999: projections using data to the end of 1994. Commun Dis Rep 1996;6:1.
16. O'Brien WA, Hartigan PM, Martin D, et al. Changes in plasma HIV-1 RNA and CD4 lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996;334:426-31.
17. Dickover RE, Garratty EM, Herman SA, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA 1996;275:599-605.
18. Centers for Disease Control and Prevention. National HIV Serosurveillance Summary: Results through 1992. Vol 3. Atlanta, GA: US Department of Health and Human Services, 1994.